Megace es and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Megace es (megestrol acetate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Revlimid, and have Pain.

The phase IV clinical study analyzes which people have Rashes when taking Megace es. It is created by eHealthMe based on reports of 601 people who have side effects when taking Megace es from the FDA, and is updated regularly.

What is Megace es?

Megace es has active ingredients of megestrol acetate. eHealthMe is studying from 611 Megace es users. Check the latest studies of Megace es.

What is Rashes?

Rashes (redness) is found to be associated with 3,715 drugs and 6,215 conditions by eHealthMe. Check the latest studies of Rashes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

601 people reported to have side effects when taking Megace es.
Among them, 15 people (2.5%) have Rashes.

Among these 15 people:

How long have people been on Megace es when they have Rashes? *

What is the gender of people who have Rashes when taking Megace es? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Rashes when taking Megace es? *

What are other drugs people take besides Megace es? *

What are other side effects people have besides Rashes? *

Weight Decreased: 8 people, 53.33%
Diarrhea: 5 people, 33.33%
Nausea (feeling of having an urge to vomit): 5 people, 33.33%
Fatigue (feeling of tiredness): 4 people, 26.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 26.67%
Muscle Spasms (muscle contraction): 4 people, 26.67%
Neuropathy Peripheral (surface nerve damage): 3 people, 20.00%
Weakness: 3 people, 20.00%
Fall: 3 people, 20.00%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 20.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 26.67%
Pain: 4 people, 26.67%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 13.33%
Skin Exfoliation (removal of the oldest dead skin cells): 2 people, 13.33%
Nausea And Vomiting: 2 people, 13.33%
Nausea (feeling of having an urge to vomit): 2 people, 13.33%
Stress And Anxiety: 2 people, 13.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 6.67%
Diabetes: 1 person, 6.67%
Diarrhea: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Megace es and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Megace es:

Megace es (611 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Megace es:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,715 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,215 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on megestrol acetate (the active ingredients of Megace es) and Megace es (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.